FDA Inspection 1059288 — I2L Research USA Inc
The FDA completed an inspection of I2L Research USA Inc on Jul 12, 2018 in Halethorpe, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 12, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Halethorpe, MD (United States)
Additional Details
Clinical BA/BE